Manufacturer Restrictions on Contract Pharmacies

Manufacturer Restrictions on Contract Pharmacies

Publication Date: July 26, 2022


This NACHC Brief explains how Gilead’s new “Contract Pharmacy Integrity Initiative” leads to manufacturer restrictions which require health centers and other covered entities to provide claims-level data from contract pharmacies. Merck has recently included Federally Qualified Health Centers (FQHCs) in their contract pharmacy restrictions when previously only hospital covered entities were impacted. Restrictions do not apply to in-house/entity owned pharmacies.


Questions? Contact us at

This publication is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $7,254,766 with 100 percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit